# Mechanisms of Cerebrovascular Control

> **NCT02936687** · PHASE1 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 59 (actual)

## Conditions studied

- Metabolic Syndrome X

## Interventions

- **DRUG:** NOS Inhibition
- **DRUG:** ET-1 Inhibition
- **DRUG:** NOS Inhibition Placebo
- **DEVICE:** 3 Tesla MRI
- **DEVICE:** Intravenous Catheter
- **OTHER:** Oral Glucose Tolerance Test
- **DRUG:** ET-1 Inhibition Placebo

## Key facts

- **NCT ID:** NCT02936687
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-31
- **Primary completion:** 2021-07-01
- **Final completion:** 2021-09-30
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2021-10-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02936687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02936687, "Mechanisms of Cerebrovascular Control". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02936687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*